TARGEPEUTICS
Targepeutics is a biopharmaceutical company developing selective molecularly targeted therapeutics to fight and diagnose cancer and other diseases. Our lead compound, GB-13, is currently advancing toward a Phase I clinical trial for several cancer targets. GB-13 is a genetically engineered recombinant protein that specifically binds and destroys cancer cells with minimal normal cell damage. We have also licensed related technology for a cancer immunotherapy that is in Phase III clinical trials.
TARGEPEUTICS
Social Links:
Industry:
Biotechnology Pharmaceutical
Founded:
1989-01-01
Address:
Hershey, Pennsylvania, United States
Country:
United States
Website Url:
http://www.targepeutics.com
Total Employee:
1+
Status:
Active
Contact:
(717) 571-2402
Technology used in webpage:
Cloudflare Hosting Unsplash
Similar Organizations
i2 Pharmaceuticals
i2 Pharmaceuticals, a biopharmaceutical company.
IsoTherapeutics Group
IsoTherapeutics Group LLC is a radiopharmaceutical company.
Jenrin Discovery
Jenrin Discovery is a biopharmaceutical Company.
Northern Therapeutics
Northern Therapeutics is a biopharmaceutical company
PharmaEngine Inc
PharmaEngine, Inc. is a biopharmaceutical company.
Vycellix
Vycellix Inc. is a biopharmaceutical company.
Current Employees Featured
Official Site Inspections
http://www.targepeutics.com
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Targepeutics"
Targepeutics - Innovative Treatment for Brain Cancer
Targepeutics has now obtained orphan drug designation for GB-13 from the Food and Drug Administration (FDA), opening paths to needed resources. GB-13 specifically targets a cancer ā¦See details»
Targepeutics - Crunchbase Company Profile & Funding
Targepeutics is a biopharmaceutical company developing selective molecularly targeted therapeutics to fight and diagnose cancer and other diseases. Our lead compound, GB-13, is ā¦See details»
Our Team - Targepeutics
Randy oversees all aspects of research at Targepeutics and facilitates and manages collaborative research projects at multiple research institutions. Prior to joining Targepeutics, he was Senior ā¦See details»
Targepeutics 2025 Company Profile: Valuation, Funding
Targepeutics was founded in 1997. Where is Targepeutics headquartered? Targepeutics is headquartered in Hummelstown, PA. What is the size of Targepeutics? Targepeutics has 3 ā¦See details»
Targepeutics Inc - Company Profile and News - Bloomberg Markets
Company profile page for Targepeutics Inc including stock price, company news, executives, board members, and contact informationSee details»
Contact - Targepeutics
Contact Get in touch with us to discuss strategic partnerships or to learn more about our plans for GB-13 clinical trials. 1214 Research Blvd., Suite 1011, Hummelstown, PA 17036 (717)571 ā¦See details»
Targepeutics - Overview, News & Similar companies - ZoomInfo
Jan 20, 2021 Who is Targepeutics. Targepeutics has an intellectual property portfolio including several issued patents and numerous additional patens pending, focused on novel targe ted ā¦See details»
Targepeutics, Inc.: Drug pipelines, Patents, Clinical trials - Synapse
Jul 1, 2023 Explore Targepeutics, Inc. with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Immune System Diseases, Technology Platform:Biological ...See details»
Targepeutics - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Targepeutics Inc. is a biopharmaceutical company. Start Free Trial . Chrome ExtensionSee details»
Targepeutics - Craft
Targepeutics is a biopharmaceutical company developing selective molecularly targeted therapeutics to fight cancer and other diseases. Its lead compound, GB-13, is a genetically ā¦See details»
TARGEPEUTICS, INC. - VentureRadar
Targepeutics is a biopharmaceutical company developing selective molecularly targeted therapeutics to fight cancer and other diseases. Our lead compound, GB-13, is currently ā¦See details»
Targepeutics - Company Profile & Staff Directory - ContactOut
Targepeutics is a biopharmaceutical company developing selective molecularly targeted therapeutics to fight and diagnose cancer and other diseases. Our lead compound, GB-13, is ā¦See details»
Nextsource | Company Profile | Targepeutics
Explore the company profile of Targepeutics (targepeutics.com) featuring business details and insights, funding data, industry info, employee numbers, and more.See details»
Targepeutics - LinkedIn
Targepeutics is a biopharmaceutical company developing selective molecularly targeted therapeutics to fight and diagnose cancer and other diseases. Our lead compound, GB-13, is ā¦See details»
TARGEPEUTICS, INC. - VentureRadar
LucasPye Bio USA n/a As a Contract Development Manufacturing Organization (CDMO), we fast-track the clinical development of your biologic for regulatory approval, manufacture your ā¦See details»
Our Mission - Targepeutics
The majority of current cancer therapies kill tumor cells but also kill normal cells, creating unwanted toxicities and side effects. As a biopharmaceutical company, we have found a ā¦See details»
Targepeutics - SPEEDA Edge
Targepeutics is a biopharmaceutical company developing selective molecularly targeted therapeutics to fight and diagnose cancer and other diseases. Our lead compound, GB-13, is ā¦See details»
Development of GB13 for the Treatment of Pediatric Diffuse ā¦
Cancer cells by leveraging IL13/receptor association. As such, Targepeutics has developed a mutated IL13-derived toxin, called GB13, that preferentially binds to IL13R 2 and possesses a ā¦See details»
Targepeutics Receives Rare Pediatric Disease Designation for GB13
Targepeutics Inc is proud to announce that the U.S. Food and Drug Administration (FDA) has granted Pediatric Rare Disease Designation (RPDD) for its investigational immunotoxin ā¦See details»
Our Model - Targepeutics
GB-13 contains an amino acid mutation in the IL13 domain that blocks binding to IL13RĪ±1 on non-cancerous cells and promotes high affinity IL13RĪ±2-specific engagement with cancer cells.See details»